- Home
- ANIX vs GNTA Comparison
ANIX vs GNTA Comparison
Compare ANIX & GNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANIX
- GNTA
- Stock Information
- Founded
- ANIX 1982
- GNTA 2014
- Country
- ANIX United States
- GNTA Italy
- Employees
- ANIX N/A
- GNTA N/A
- Industry
- ANIX Biotechnology: Pharmaceutical Preparations
- GNTA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ANIX Health Care
- GNTA Health Care
- Exchange
- ANIX Nasdaq
- GNTA Nasdaq
- Market Cap
- ANIX 91.7M
- GNTA 96.0M
- IPO Year
- ANIX 1987
- GNTA 2021
- Fundamental
- Price
- ANIX $2.53
- GNTA $5.15
- Analyst Decision
- ANIX Strong Buy
- GNTA Strong Buy
- Analyst Count
- ANIX 2
- GNTA 1
- Target Price
- ANIX $8.50
- GNTA $25.00
- AVG Volume (30 Days)
- ANIX 102.1K
- GNTA 5.3K
- Earning Date
- ANIX 01-14-2025
- GNTA 01-01-0001
- Dividend Yield
- ANIX N/A
- GNTA N/A
- EPS Growth
- ANIX N/A
- GNTA N/A
- EPS
- ANIX N/A
- GNTA N/A
- Revenue
- ANIX N/A
- GNTA N/A
- Revenue This Year
- ANIX N/A
- GNTA N/A
- Revenue Next Year
- ANIX N/A
- GNTA N/A
- P/E Ratio
- ANIX N/A
- GNTA N/A
- Revenue Growth
- ANIX N/A
- GNTA N/A
- 52 Week Low
- ANIX $2.15
- GNTA $2.20
- 52 Week High
- ANIX $5.13
- GNTA $7.28
- Technical
- Relative Strength Index (RSI)
- ANIX 26.19
- GNTA 50.97
- Support Level
- ANIX $2.80
- GNTA $4.60
- Resistance Level
- ANIX $3.43
- GNTA $5.27
- Average True Range (ATR)
- ANIX 0.20
- GNTA 0.28
- MACD
- ANIX -0.06
- GNTA -0.00
- Stochastic Oscillator
- ANIX 1.10
- GNTA 42.64
About ANIX Anixa Biosciences Inc.
Anixa Biosciences Inc, a cancer-focused biotechnology company, developing vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.
About GNTA Genenta Science S.p.A.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain, and TEMs -Immuno-Gene Therapy.